We are live on
!
Find out more
ACM
Abrams Capital Management Portfolio holdings
AUM
$4.64B
1-Year Est. Return
1.52%
This Fund
S&P 500
This Quarter
Est. Return
+19.23%
1 Year Est. Return
-1.52%
3 Year Est. Return
+72.02%
5 Year Est. Return
+85.41%
10 Year Est. Return
+362.14%
AUM
$3.16B
AUM Growth
+$358M
(+13%)
Cap. Flow
-$63.3M
Cap. Flow
% of AUM
-2%
Top 10 Holdings %
Top 10 Hldgs %
91.93%
Holding
16
New
–
Increased
1
Reduced
3
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLP
Cantaloupe
CTLP
|
+$21.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$78.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$4.24M |
| 3 |
Asbury Automotive
ABG
|
+$2.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 45.7% |
| 2 | Communication Services | 22.1% |
| 3 | Industrials | 15.31% |
| 4 | Energy | 7.03% |
| 5 | Financials | 6.13% |
Similar funds
VCM
LPPI
KCM
DWM
ASC
CWG
ANTB
MA
Abrams Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Abrams Capital Management held 16 positions worth $3.16B, up 13% from $2.8B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 0%. Abrams Capital Management opened no new positions and made no exits, leaving the 16-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, down from 46% a quarter earlier, followed by Communication Services and Industrials.
- Abrams Capital Management added most to Cantaloupe in Q1 2023, an estimated $21.8M increase.
- Abrams Capital Management's biggest Q1 2023 reduction was Teva Pharmaceuticals, cutting an estimated $78.8M.
- Abrams Capital Management's ten largest holdings make up 92% of its $3.16B portfolio in Q1 2023.
- Abrams Capital Management opened 0 new positions and closed 0 in Q1 2023.
- Abrams Capital Management's portfolio value rose 13% quarter-over-quarter to $3.16B.
Based on Abrams Capital Management's 13F filing for Q1 2023, filed 12 May 2023.